Object. During a 5-year period 317 patients presenting with aneurysmal subarachnoid hemorrhage were successfully treated by coil embolization within 30 days of hemorrhage. The authors followed these cases to assess the stability of aneurysm occlusion and its longer-term efficacy in protecting patients against rebleeding.
in the first few months after rupture, [7, 17, 30, 40] when rebleeding is most frequent. [56] However, aneurysm recurrence may occur as a result of subtotal packing or compaction of the coil-thrombus complex, [14, 24] which raises concerns about the ability of coil embolization to protect against aneurysm regrowth and/or rerupture in the long term. [4, 30, 42] To date, reports of patients treated by coil embolization for intracranial aneurysms have concentrated on short-term efficacy and procedural safety. The larger series generally include patients presenting with both ruptured and unruptured aneurysms [5, 9, 30, 40, 46] or do not provide details of follow-up angiography and long-term outcome. [4, 7, 41, 55] This study was performed to provide data on the stability of endosaccular packing of ruptured aneurysms during the acute phase by using GDCs over the first 6 months posttreatment and its long-term efficacy in protecting against rebleeding. Such data are needed to establish follow-up protocols and the place of this novel technology in the management of aneurysmal SAH.
CLINICAL MATERIAL AND METHODS
During a 5-year period (July 1992-June 1997) 465 patients underwent endovascular treatment for intracranial aneurysms. This study involves 317 of these patients who were successfully treated during the acute phase after suffering aneurysmal SAH. The study population was composed of 191 women (60.3%) and 126 men (39.7%). The mean age of the patients at presentation was 50.5 years (range 22-82 years). The age distributions by decade are presented in Table 1 . The entry criteria for patients included: 1) a clinical diagnosis of SAH supported by either computerized tomography scanning or a xanthochromic cerebrospinal fluid sample, and 2) coil embolization by endosaccular packing performed within 30 days of the last hemorrhage, which successfully occluded the aneurysm. Patients who had undergone an unsuccessful craniotomy and attempted clipping of a ruptured aneurysm were included in this definition. The other 148 patients treated during this period were excluded from the study because they were treated for unruptured aneurysms or were treated more than 30 days after their last SAH.
Selection of patients for coil embolization rather than surgical clipping was made by consultation between a neurosurgeon and an interventional neuroradiologist. At the start of the study, only patients considered to be at high risk for surgical clipping were recruited, usually on the basis of aneurysm location (such as posterior circulation or carotid ophthalmic aneurysms) or poor clinical status due to the SAH, a coexisting medical condition, or extreme old age. An angiographic assessment of the aneurysm's suitability for endovascular treatment was made. The criteria were that the neck of the aneurysm was sufficiently discrete to retain coils and that treatment could be performed without compromising the parent or adjacent artery. Since 1994 some patients with anterior circulation aneurysms that were clippable and in whom clinical equipoise existed after the aforementioned assessments were offered entry into an ongoing multicenter randomized trial (International Subarachnoid Aneurysm Trial [ISAT]). After informed consent was obtained, these patients were randomly allocated to endovascular treatment or surgery.
Coil embolization was performed as soon as possible after admission to our institution. The procedures were performed within 2 days of aneurysm rupture in 91 patients (28.7%) and within 2 weeks in 253 patients (79.8%) ( Table 2) . Because referrals were made by both local and distant neurosurgeons, the series includes a relatively high proportion of good-grade patients, reflecting a tendency to restrict transfer to patients who were well enough to travel. Because of inevitable delays, clinical status was recorded using the World Federation of Neurosurgical Societies (WFNS) grading score [10] at the time of treatment rather than at the time of admission ( Table 2 ). Endovascular treatment was performed using GDCs to pack the body of the aneurysm sac as densely as possible and, thereby, obstruct the neck. Our technique and procedure protocol have been previously described. [7] In patients with multiple aneurysms, the aneurysm believed to have caused the hemorrhage was treated first and coincidental aneurysms were treated during the same procedure or subsequently by either GDC embolization or surgical clipping.
The locations of the aneurysms assumed to have ruptured are presented in Table 3 . The termination (or bifurcation) of the BA was the most common location with 76 aneurysms (24%); 111 aneurysms (35%) were located in the posterior cerebral circulation. The primary aneurysm was treated in one session in all but two patients in whom treatment required two sessions.
Multiple aneurysms were present in 83 patients (26.2%); the site details of these aneurysms are presented in Table 4 . Eight of these patients had three aneurysms, four patients had four, one patient had five, and one patient had six aneurysms. In all, 97 coincidental aneurysms were diagnosed. Forty-seven of these aneurysms were treated during the study period: 43 by coil embolization and four by microsurgical clipping.
Cases were followed by clinical review and repeated intraarterial angiography at 6 months, although in some patients angiography was performed between 6 and 12 months after completion of treatment, in others it was conducted earlier (2-3 months) because of concern about the completeness of the embolization at the time of treatment. Thereafter, patients were contacted by mail and asked to fill out follow-up questionnaires. Specific inquiry about further intracranial hemorrhage was made and patients, their families, or their referring physicians were contacted to provide details of current status in patients who failed to respond to the questionnaire. The questionnaire design was based on that used in the International Stroke Trial (IST) and ISAT to collect a modified Rankin score, with a Rankin score of 0 or 1 being assigned Glasgow Outcome Scale [25] (GOS) score 5, Rankin score 2 assigned GOS score 3, Rankin score 3 or 4 assigned GOS 3, and Rankin score 5 assigned GOS score 2. Patients who died were assigned a GOS score of 1. This instrument has been validated in the IST. [28] Patients remained in the study until they died, rebleeding occurred, or surgical clipping or arterial occlusion was performed in the management of recurrence. In the first 30 days postprocedure, 11 patients died and four patients who were discharged from the hospital in satisfactory condition were lost to follow-up review. During the period of 1 to 6 months posttreatment, five patients died, one due to rebleeding (Case 1) and four of causes unrelated to the procedure. Follow-up periods were calculated for each patient as the number of days between the treatment date and the date of last contact. These data were used to calculate Kaplan-Meier graphs for survival time and rebleeding-free survival time. The risk of rebleeding during the study period was, thereby, calculated for each patient's follow-up year and related to the number of patients at risk of rebleeding. The longest follow-up time was 1982 days (65 months), median 670.5 days (22.3 months).
RESULTS

Clinical Outcome
In the 313 patients for whom we have data, clinical outcomes at 6 months were as follows: 199 patients (63.5%) made complete recoveries (GOS score 5), 56 (17.9%) made good recoveries (GOS score 4), 31 (9.9%) were moderately disabled (GOS score 3), 11 (3.5%) were severely disabled (GOS score 2) and 16 (5.1%) had died (GOS score 1). These outcomes and relevant pretreatment WFNS grades are presented in Table 5 . In this series there was a relatively high proportion of patients classified as WFNS Grade 1 compared with WFNS Grade 2, which reflects the difficulty sometimes experienced in separating these grades. For this reason the two have been amalgamated for analysis. Excellent or good outcomes measured at 6 months posttreatment were achieved in 87.8% of patients with WFNS Grades 1 and 2, in 71.4% of patients with WFNS Grade 3, and in 48.5% of patients with WFNS Grades 4 and 5 at the time of treatment; overall excellent or good outcomes were achieved in 81.5% of patients. The mortality rates (all causes) at 6 months posttreatment were 4.3% (95% confidence interval [CI] 1.8-6.4%) for patients with WFNS Grades 1 to 3; 12.1% (95% CI 0.9-23%) for patients with WFNS Grades 4 and 5; and 5.1% (95% CI 2.6-6.3%) for all patients.
Angiographic assessment of the degree of occlusion was made in 259 aneurysms in 250 (84.2%) of the available 297 patients between 6 and 12 months after coil embolization. Some of the patients were not studied because they were in a poor grade and it was judged inappropriate because additional treatment would not be recommended, the patient had returned to a foreign country, or the patient refused further assessment. The findings, according to aneurysm size, are presented in Table 6 .
Following treatment 165 (64%) of these 259 aneurysms were completely occluded, 89 (34%) had a small remnant (> 95% occlusion), and five (2%) had more substantial residual filling (< 95% occlusion). Recurrence (or unstable occlusion) was defined as an increase in the amount of contrast filling the aneurysm relative to the end-of-treatment angiographic appearance of the aneurysm. An aneurysm was classified as stable at follow-up review if the degree of occlusion was unchanged or had improved relative to the end-of-treatment study. Stable occlusions were present in 86.4% of the small aneurysms, 85.2% of the large aneurysms, and neither of the two giant aneurysms. Overall, 221 aneurysms (85.3%) remained stable and 38 (14.7%) enlarged to some degree. As well as recurrence, angiography demonstrated improved degrees of occlusion in 22 aneurysms (8.5%) (11 small and 11 large) due to thrombosis subsequent to the completion of packing with coils and the reversal of periprocedural anticoagulation. Recurrent aneurysms were treated with endovascular coil or balloon occlusion of the aneurysm-bearing artery in 11 patients; two patients underwent surgical clipping and two patients refused further treatment. The remaining patients continue to be observed.
Rebleeding
Five patients suffered recurrent spontaneous SAH. These events occurred between 5 and 35 months after coil embolization. Details on the patients and their aneurysms are listed in Table 7 .
Rebleeding in Case 1 was caused by rupture of a coincidental untreated aneurysm. In Case 2, angiography revealed recurrence of a pericallosal aneurysm at the 6-month follow-up angiography session (Fig. 1) . The patient declined further treatment and suffered a fatal rebleeding 18 months after the original treatment. (Table 7) . Intraarterial subtraction angiograms demonstrating a small distal ACA aneurysm following coil embolization (left) and 6 months later (right). Recurrent filling was due to compaction of coils at the aneurysm neck. The patient declined further treatment.
The patient in Case 3 underwent two attempts to clip a large terminal internal carotid artery aneurysm before being referred for coil embolization. Stable residual filling of the aneurysm was evident at 6 months; however, this extended with recurrence of the aneurysm at the time of rebleeding 5 months later.
The (Fig. 2) . Table 7) . Intraarterial angiograms obtained after coil embolization (left) and 30 months later (right), following rebleeding. There is residual filling (left), which at the 6-month follow-up angiographic session consisted of an inflow pocket. Further coil compaction occurred, as there is a substantial recurrent aneurysm sac.
Three of these patients survived recurrent hemorrhage. Two were retreated by endovascular coiling and one by surgical clipping. All three made good recoveries. Thus three (7.9%) of 38 aneurysms with an unstable occlusion and one (0.4%) of 221 aneurysms with a stable occlusion observed on 6-month follow-up angiography later reruptured.
The overall survival rate and number of patients at risk during each follow-up year are presented in Table  8 . Annual rebleeding rates were 0.8% in the 1st year, 0.6% in the 2nd year, and 2.4% in the 3rd year (Table 9) . No further rebleeding occurred in the 67 patients who were observed beyond 3 years (Table 9) and no rebleeding was documented in those patients who did not undergo follow-up angiography.
DISCUSSION
The potential benefit of endovascular treatment to patients with recently ruptured intracranial aneurysms is protection from rebleeding at the minimum risk of iatrogenic morbidity. The arguments for avoiding craniotomy by exploiting the endovascular route after aneurysmal SAH have encouraged attempts to isolate aneurysms from the cerebral circulation by endosaccular packing with balloons, coils, and liquid embolic agents. Treatment results have been varied and have failed to convince many neurosurgeons that they are effective alternatives to microsurgical clipping in all but selected patients with high-risk aneurysms. This was hardly surprising when endosaccular embolization with balloons, for example, was associated with mortality rates as high as 18% for all patients [22] and 22% for those with small aneurysms. [47] However more recent reports of outcomes in patients treated by endosaccular packing with detachable coils [7, 30, 40, 44, 55] have challenged the view that microsurgical clipping remains the treatment of choice for all recently ruptured aneurysms. In this situation, the two treatment approaches need to be compared in a prospective randomized trial to avoid historical bias and, preferably, in a large multicenter study such as the ongoing ISAT to compare a broad range of technical expertise.
In the absence of such data, this study has been performed to assess medium-term outcomes and rebleeding risks for patients with intracranial aneurysms treated by coil embolization in the acute and recovery phases following rupture. It is important to bear in mind the demographic characteristics of our patients, which vary from those listed in previous surgical reports because patient selection was made on the basis of anticipated surgical difficulty and because of delays in patient transfers from other neurosurgical centers. The treated cohort thus contains a relatively large proportion of WFNS Grade 1 patients treated relatively long after SAH, which would be expected to improve the overall outcome results, but may be counterbalanced by a higher proportion of posterior circulation aneurysms than most surgical series. Treatment outcomes in this study are similar to those of other endovascular series; Raymond and Roy [44] treated two thirds of their 75 patients within 48 hours of hemorrhage and reported excellent or good outcomes at 6 months in 72% of the patients. These results are also similar to recently reported series of patients treated by microsurgical clipping after aneurysmal SAH, in which excellent or good outcomes (GOS scores 4 and 5) were achieved in 74 to 89% of patients presenting with Hunt and Hess Grades I to III. [2, 13, 43, 51] In a recent large prospective randomized study of tirilazad [21] involving 902 patients it was reported that 67 to 76% of patients with good outcome or moderate disability at 3 months, with more than 90% of the patients treated surgically. Among our patients, those with WFNS Grade IV or V at the time of treatment did particularly well when compared with surgical mortality rates of 35 to 45% reported by the International Cooperative Study in these subgroups. [26] Fundamental to the prognosis after aneurysmal SAH is the protection against rebleeding provided by any treatment. It has long been recognized that incomplete aneurysm obliteration by surgical clipping is associated with rebleeding [11, 12] and that aneurysm neck remnants or rests can enlarge. [27] Incidences of incomplete aneurysm obliteration of approximately 4% have been reported on follow-up angiography. [3, 12, 15, 27, 29, 32] Feuerberg, et al., [15] found aneurysm rests in 3.8% of 715 treated patients and, in a study of 66 patients, Macdonald and associates [29] unexpectedly found 4% of aneurysms that were incompletely clipped and another 4% totally unclipped on postoperative angiography. Regrowth and rebleeding may occur after apparently complete occlusion [27] and no constant rate of regrowth has been determined. [1, 27] Aneurysm wrapping, on the other hand, is a far less secure method of protecting patients: Todd, et al., [53] recorded an incidence of early rebleeding (within 6 months) of 8.6% and annual delayed rebleeding rates ranging from 1.5 to 4.5% have been reported. [37, 53] Angiographic findings after coil embolization should be considered against this background. However, it should be appreciated that some change in the degree of occlusion after the end-of-treatment angiogram is to be anticipated and comparisons with postclipping angiography are difficult. It is assumed that an aneurysm completely obliterated by a surgical clip is very unlikely to regrow. Residual filling of the lumen or neck region is more frequent after coil embolization and, even after complete initial occlusion, the degree of occlusion is not necessarily as stable. Angiographic follow-up examination, therefore, has to determine the completeness of the embolization and its stability over time. In the design of this study, we arbitrarily elected to perform follow-up angiography at 6 months. This interval was chosen to ensure that post-SAH vasospasm would not influence the degree of occlusion and that any tendency for aneurysm regrowth might be recognized. It also coincided with the end of the period in which patients are at highest risk of rebleeding. [56] Our results show that the degree of aneurysm obliteration changed over this period to a far greater extent than would be expected following aneurysm clipping; the completeness of obliteration improving in 8.5% and deteriorating in 14.7% of aneurysms.
Incomplete occlusion was present at some stage in all four patients who rebled from treated aneurysms. This is hardly surprising but disappointingly, the 6-month angiography session showed a stable remnant in one patient and failed to anticipate subsequent recurrence and rebleeding. Stable thrombosis has been demonstrated in experimental aneurysms constructed in various animal species and studied for up to 6 months; [6, 35] however, as late as 6 months after treatment, Reul and colleagues [45] found a lack of organized thrombus around coils at the neck of bifurcation aneurysms in rabbits. There are few reports of human postmortem examinations [31, 38, 39] and these have shown poorly organized or unorganized intraaneurysmal thrombus. Coils that protruded into the recurrent lumen of a large PCoA aneurysm, reported by Manabe, et al., [31] were covered only by a thin transparent membrane. These findings suggest that the coil-thrombus complex at orifices of larger aneurysms subjected to hemodynamic forces of axial blood flow fail to form a normal endothelial cell layer. It can, therefore, be speculated that some degree of neck reopening after coil embolization may be a benign consequence of thrombus organization and fibrosis around the coils because the majority of small and large aneurysms in this study remained stable over 6 months, although it is difficult to imagine that this process, once initiated, is not progressive.
This study supports previously reported observational studies that endosaccular coil embolization protects patients against rebleeding in the first 6 months. [7, 17, 30, 40, 44] However, care should be taken in this interpretation because the cohort contains a relatively small percentage of patients who were treated within 48 hours of bleeding and delaying treatment may select a subgroup at reduced risk of rebleeding. That patients treated by coil embolization up to now may have a lower risk of rebleeding is supported by the relatively high rate of incomplete occlusion following coil embolization. A neck or more substantial remnant was present in 36% of aneurysms in this study, but the single instance of rebleeding during this period was caused by rupture of an untreated coincidental aneurysm. Delayed (> 6 months) rebleeding after coil embolization has been previously reported. [9, 30, 31, 44] These studies found that incomplete occlusion of the aneurysm lumen due to large size, [30] incomplete packing, [9, 44] and coil compaction leading to aneurysm recurrence [31] were causes. Follow-up angiography at 6 months in this study demonstrated more frequent instability in larger aneurysms but rebleeding, which was far less frequent, occurred in patients with both large and small aneurysms.
Rebleeding is a rare complication after microsurgical clipping, but has been reported to affect 0.5 to 2% of patients. [11, 43, [50] [51] [52] Feuerberg, et al., [15] reported a 3.7% incidence of rebleeding among patients with aneurysm rests observed for 8 years. They calculated an annual rebleeding risk of 0.38% in patients with incompletely clipped aneurysms and 0.79% in those with patent rests. In this study the same calculation (dividing the number of rebleeding patients by the number of follow-up years) gives an annual rebleeding rate of 0.82%; however, this method tends to underestimate the rate and, in this instance, failed to identify the higher rate in Year 3 (Table 8 ). This latter finding supports the concept that coil compaction and aneurysm recurrence take time (probably > 6 months) to develop. The incidences of rebleeding (7.9% in patients with unstable aneurysms and 0.4% in those with stable occlusions), although high, do provide reassurance that complete occlusion is protective and do not suggest that regrowth and rebleeding are inevitable consequences of incomplete occlusion.
Long-term observational studies with large numbers of patients are needed to confirm the findings of this study and assess the time scale for postembolization aneurysm recurrence. The interval between clipping and rebleeding is often years: Giannotta and Litofsky [16] reported an average interval of 10.5 years and rebleeding due to regrowth has been reported as late as 17 years after clipping. [49] Longitudinal studies must, therefore, be prolonged. The large numbers of patients needed will require collaboration within multicenter trials or the establishment of national and international registers of treated patients. Although it is likely that the frequency of aneurysm recurrence after coil embolization will diminish as improvements are made in the design of coils, such as the recently introduced soft coils that allow denser packing, periodic follow-up angiography should be performed as part of the treatment plan. These studies are needed to exclude the occurrence of coil compaction and, should aneurysm regrowth occur, it warrants careful observation if not early retreatment (either by coil embolization or microsurgical clipping).
